Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar syazic (71.55) Submitted: 3/28/2011 4:56:52 PM : Outperform Start Price: $7.27 ARIA Score: +128.45

UPWARD trend is set.

Report this Post Reply

Featured Broker Partners


Advertisement